UK-Based Named Patient
Medicine Supply
for Hospitals & Institutions
Euro Biom is an MHRA WDA-licensed pharmaceutical wholesaler trading exclusively in UK-licensed medicines, specialising in sourcing and supply for named-patient import by hospitals, procurement teams and NGOs internationally.
Same-day response to every enquiry · Mon-Fri 09:00-18:00 · WhatsApp us
alternative exists.
A named patient medicine is a medicine imported for an identified patient under the importing country's named-patient route, when no locally registered product is available or clinically appropriate.
The prescribing doctor takes clinical responsibility for the decision to use a product not yet registered in their market. The supplier, Euro Biom, takes responsibility for sourcing through the UK licensed supply chain, arranging the cold chain, and providing GDP documentation.
This service is also used internationally, where a medicine is registered in the UK but not in the destination country, or where the patient requires a specific formulation, strength or presentation unavailable locally.
and Clinical Procurement
Named patient supply is used by a wide range of healthcare buyers. If your usual supplier cannot find a UK-licensed medicine, we can check the UK licensed supply chain.
The licences that make
this supply legal and traceable.
Named-patient import supply must be handled at the UK end by an MHRA-licensed Wholesale Dealer. Euro Biom holds the correct authorisations to procure, supply and export UK-licensed medicines compliantly.
MHRA Wholesale Dealer Authorisation
Euro Biom holds WDA(H) 59239, granted by the Medicines and Healthcare products Regulatory Agency. This authorisation is publicly verifiable on the MHRA register.
GDP Good Distribution Practice
All products are handled in accordance with UK Good Distribution Practice guidelines. Shipments include a chain-of-custody record, temperature monitoring where required, and batch-level documentation.
Destination Named-Patient Import Routes
Importing countries operate named-patient and special-import routes, such as SAHPRA Section 21 in South Africa and GCC Ministry of Health import permits, for medicines not yet registered locally. Euro Biom supplies the UK-licensed medicine only on the basis of a prescriber's clinical decision and documented patient need.
International Export
Our WDA authorises export of UK-licensed medicines for named-patient import, subject to DHSC export restrictions and destination rules. We prepare the UK export documentation and can help obtain Certificates of Free Sale where required, and can point you to the import requirements published by the destination regulator.
Step by Step
Our process is designed to be fast, clear and compliant at every stage.
Named patient requirements arise most frequently in specialty and rare disease medicine. Named-patient import requests arise across the following therapeutic categories.
for the fastest response.
The more detail you provide upfront, the faster we can assess sourcing options and respond with availability and lead times. None of these fields are mandatory to start, but each one speeds up the process.
Submit a Named Patient Enquiry →Same-day response · WhatsApp us directly
Ready to Submit a Named Patient Enquiry?
Tell us what you need. We respond the same working day with sourcing options, availability and lead times. No commitment required at enquiry stage.
Common questions from hospital pharmacists, procurement managers and international buyers.
Further reading for hospital pharmacists and procurement teams.
Get a tailored quote: Named Patient Import Supply
Tell us what you need and our team responds the same working day. UK-licensed, MHRA WDA(H) 59239, verify on the MHRA register.